From 13th to 15th of October, 2015, Grindeks and its subsidiary \u201cKalceks\u201d participate in the leading pharmaceutical exhibition \u201cCPhI Worldwide 2015\u201d in Madrid, Spain.<\/p>\n\n\n\n
During the exhibition both Grindeks and \u201cKalceks\u201d representatives will discuss cooperation opportunities with their business partners, while potential cooperation partners will be introduced to products and services by both companies. The joint Grindeks and \u201cKalceks\u201d exhibition stand will be placed in the Hall 10 with number 10G41<\/strong>.<\/p>\n\n\n\n Grindeks will promote cooperation in the following business fields:<\/strong><\/p>\n\n\n\n \u00b7 Complicated, multi-stage synthesis of APIs; As Grindeks branches and representative offices are represented in 13 countries during the exhibition other pharmaceutical companies will be offered to cooperate in the sales and marketing of their products in Russia and other CIS countries. The company will also inquire in-licensing opportunities of new products and meet with its existing business partners of raw material field.<\/p>\n\n\n\n The Chairman of the Board of JSC Grindeks Juris Bundulis: \u201cParticipation in the pharmaceutical field\u2019s leading event \u201cCPhI Worldwide\u201d not only let us to strengthen the cooperation with our existing partners but it also represents the company for new potential partners. While competing in the global pharmaceutical market one of the biggest Grindeks advantages is the ability to provide vertically integrated or complete manufacturing cycle from the development of the active pharmaceutical ingredient to the manufacturing of the final dosage form. \u201d<\/p>\n\n\n\n One of the most successful vertically integrated Grindeks products is oxytocin whose both active pharmaceutical ingredient and final dosage form \u2013 injection \u2013 are being manufactured at Grindeks. The company\u2019s product range of vertically integrated production also includes zopiclone, imatinib and UDCA.<\/p>\n\n\n\n \u201cKalceks\u201d will promote cooperation<\/strong> in the research, development, manufacturing, as well as sales and out-licensing of sterile generics medication.<\/p>\n\n\n\n By participating in the exhibition the company is planning to expand its business activities in new markets. \u201cKalceks\u201d mainly specializes in CNS medication therapeutic group including products for anaesthesia and analgesia in hospital segment.<\/p>\n\n\n\n \u201cCPhI Worldwide\u201d is the world\u2019s most important pharmaceutical exhibition, which, in 2015, is held for the 26rd time and gathers pharmaceutical product manufacturers and related industry representatives from all over the world.<\/p>\n\n\n\n The participation of Grindeks in \u201cCPhI Worldwide 2015\u201d is co-financed by the European Regional Development Fund.<\/p>\n","protected":false},"excerpt":{"rendered":" From 13th to 15th of October, 2015, Grindeks and its subsidiary \u201cKalceks\u201d participate in the leading pharmaceutical exhibition \u201cCPhI Worldwide 2015\u201d in Madrid, Spain. During…<\/p>\n","protected":false},"author":3,"featured_media":1471,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1470","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/posts\/1470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/comments?post=1470"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/posts\/1470\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/media\/1471"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/media?parent=1470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/categories?post=1470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/en\/wp-json\/wp\/v2\/tags?post=1470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\u00b7 FDF development and manufacturing of tablets, capsules, injections and topical forms;
\u00b7 Customized contract manufacturing of FDF
\u00b7 Out-Licensing and sales of generic medication
\u00b7 Pharmaceutical product analysis, analytical method development and validation<\/p>\n\n\n\n